IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
The Veterinary Pharmaceutical and Medicinal Product Manufacturing industry has endured mixed operating conditions over the past few years. The agriculture sector has been a vital market for veterinary pharmaceutical and medicinal product manufacturers. Demand from beef cattle farming has remained relatively robust, but a diminishing number of sheep has reduced demand for veterinary medicines. Veterinary pharmaceutical and medicinal product manufacturers have faced challenges as consumer preferences have shifted towards less costly, generic veterinary pharmaceutical and medicinal products, which has heightened competition from imports. Growing public concern about antimicrobial resistance has reduced antibiotic sales.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand includes market sizing, forecasting, data and analysis from 2015-2030. The most recent publication was released July 2025.
The Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand operates under the ANZSIC industry code C1842NZ. The Veterinary Pharmaceutical and Medicinal Product Manufacturing industry has manufacturers that primarily manufacture drugs, medicines, medicinal chemicals, vaccines, serums and other pharmaceutical products for veterinary use. Related terms covered in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand include analgesics, anaesthetics, companion animal and dermatology.
Products and services covered in Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand include Paraciticides, Vaccines and Antibiotics.
Companies covered in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand include Schering-Plough Animal, Zoetis New Zealand and Virbac New Zealand.
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
The Products and Markets chapter covers detailed product and service segmentation, analysis of major markets and international trade data for the for the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
The Companies chapter covers Key Takeaways, Market Share and Companies in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
The market size of the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand is $584.4m in 2026.
There are 39 businesses in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand, which has grown at a CAGR of 1.6 % between 2020 and 2025.
The Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand is likely to be impacted by import tariffs with imports accounting for a moderate share of industry revenue.
The Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand is likely to be impacted by export tariffs with exports accounting for a moderate share of industry revenue.
The market size of the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand has been declining at a CAGR of 4.8 % between 2020 and 2025.
Over the next five years, the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand is expected to grow.
The biggest companies operating in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand are Schering-Plough Animal, Zoetis New Zealand and Virbac New Zealand
Parasiticides manufacturing and Immunotherapy product manufacturing (including vaccines) are part of the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
The company holding the most market share in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand is Schering-Plough Animal.
The level of competition is moderate and increasing in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.